MedTrace Logo

The Use of A Prebiotic to Promote a Healthy Gut Microbiome in Pediatric Stem Cell Transplant Recipients

NCT04111471 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2024-11-21

No results posted yet for this study

Summary

This study will look at the effect of the prebiotic inulin compared to placebo on children undergoing stem cell transplant.

Conditions

  • Microbial Colonization

Interventions

DIETARY_SUPPLEMENT

Prebiotics

Enrolled patients will receive 10 grams of inulin daily for 21 days

DIETARY_SUPPLEMENT

Placebos

Enrolled patients will receive 5.6 grams of placebo powder daily for 21 days

Sponsors & Collaborators

  • Ann & Robert H Lurie Children's Hospital of Chicago

    lead OTHER

Principal Investigators

  • Mehreen M Arshad, MD · Lurie Children's/Northwestern

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-31
Primary Completion
2024-11-18
Completion
2024-11-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04111471 on ClinicalTrials.gov